Skip to main content
. 2017 Aug 26;15(3):1026. doi: 10.18549/PharmPract.2017.03.1026

Table 2. Difference in level of adherence intervention and control groups at baseline, 3 and 6 months.

Adherence (Morisky score) MTM (n=54) Non-MTM (n=53)
Good Poor p-value Good Poor p-value
At baseline 5 (9.2%) 49 (90.8%) <0.001 7 (13.2%) 46 (86.8%) 0.462
3 months 16 (29.6%) 38 (70.4%) 0.020 11 (20.7%) 42 (79.3%) 0.351
6 months 33 (61%) 21 (39%) <0.001 16 (30.2%) 37 (69.8%) 0.261
HHS Vulnerability Disclosure